LifeScience
New cell population identified in Alzheimer's Disease allows better targeting of macrophage populations in treatment of neurodegeneration
An Immunity research study has found that the previously identified disease associated microglia (DAM) population detected in murine Alzheimer’s dise...
October 11, 2022 | News
Pall Corporation Launches Three New Allegro™ Connect Systems
Pall Corporation extends its bioprocessing solution portfolio with the launch of three new Allegro Connect Systems. In conjunction with Pall’s Allegr...
September 28, 2022 | News
Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor
NMS-293 is a next generation, orally available, brain-penetrant PARP1 selective inhibitor NMS-293 is currently studied in Phase I as monotherapy for the...
September 27, 2022 | News
IQVIA Market Reflection Report pins JB Pharma as the fastest growing Pharma Company with a growth rate of over 20% for the month of August 2022
JB Pharma is sitting pretty, ranked at a healthy 23 among the Indian Pharmaceutical players and underlining its meteoric rise with an outstanding growth ra...
September 22, 2022 | News
ClavystBio launches to translate life sciences breakthroughs into health impact
ClavystBio, a company established by CLA Real Estate Holdings, a wholly-owned subsidiary of Temasek, today announced its launch to accelerate the commercia...
September 15, 2022 | News
Cytiva launches BioChallenge in Southeast Asia to support biotech startup development
BioChallenge facilitates access to Cytiva's services and expertise to scale up efficiently, mitigate risks and reduce time to go to market Application p...
September 12, 2022 | News
Merck strengthens its manufacturing capabilities for single-use assemblies by investing more than € 130 million in Molsheim, France.
Increases manufacturing capacity for the Mobius® single-use portfolio Creates more than 800 jobs by the end of 2028 Investment further strengt...
September 12, 2022 | News
Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East
Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...
September 02, 2022 | News
Mayo Clinic, Hibiscus BioVentures and Innoforce Announce Mayflower Cell and Gene Therapy Accelerator
This academic and industry relationship will establish independent cell and gene therapy companies to advance the development of Mayo Clinic technologies t...
September 01, 2022 | News
Biocytogen Expands Partnership with Merck
Under the terms of the agreement, Merck will have full access to Biocytogen’s RenMiceTM platform to discover and develop fully human antibo...
August 29, 2022 | News
Forecyte Bio and Cytiva team up to accelerate development and manufacturing of cell and gene therapies
Cytiva, a global life sciences leader, and ForecyteBio, a cell and gene therapy (CGT) contract development and manufacturing organization (CDMO), are ...
August 25, 2022 | News
Thermo Fisher Scientific Expands Viral Vector Manufacturing Capabilities
Thermo Fisher Scientific, the world leader in serving science, today expanded its cell and gene therapy capabilities with the opening of its new previ...
August 24, 2022 | News
Sartorius to acquire Albumedix, strengthening its portfolio of innovative advanced therapy solutions
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapi...
August 23, 2022 | News
Merck to Acquire Chemical Business of Mecaro
Acquisition supports “Level Up” growth ambition of Merck’s Electronics business to further expand its regional capabilities and global ...
August 18, 2022 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
